- Home
- WGRX
as 03-28-2025 4:00pm EST
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a seamless prescription ecosystem through an integrated technology platform, wholesale distribution, and fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 140.2M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 183.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.32 - $5.69 | Next Earning Date: | 01-01-0001 |
| Revenue: | $18,128,831 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Wellgistics Health Inc. Common Stock News
WGRX Breaking Stock News: Dive into WGRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025
GlobeNewswire
11 days ago
Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models
MT Newswires
24 days ago
Wellgistics Health Appoints Brian Norton to Succeed Tim Canning as CEO
GlobeNewswire
25 days ago
Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure
GlobeNewswire
25 days ago
Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™
GlobeNewswire
a month ago
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market
ACCESS Newswire
a month ago
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
GlobeNewswire
a month ago
Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering
Compare WGRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WGRX Wellgistics Health Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.